Parkman Healthcare Partners’s Establishment Labs ESTA Stock Holding History

Parkman Healthcare Partners’s Portfolio ESTA Stock Details ESTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-60,530	Closed	-$2.97M	–	95
2023 Q3	$2.97M	Buy	60,530 +2,447	+4%	+$146K	0.54%	55
2023 Q2	$3.99M	Buy	58,083 +33,083	+132%	+$2.29M	0.69%	46
2023 Q1	$1.69M	Buy	+25,000	New	+$1.71M	0.37%	62
2022 Q4	–	Sell	-15,173	Closed	-$829K	–	87
2022 Q3	$829K	Buy	+15,173	New	+$907K	0.24%	76

Other funds holding ESTA

JAM

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Findell Capital Management New York $341M AUM 135.6% 1-Year Est. Return

FSC

Fourth Sail Capital Camana Bay Grand Cayman, Cayman Islands $608M AUM 48.69% 1-Year Est. Return

Parkman Healthcare Partners's ESTA Position: Q4 2023 in Review

Parkman Healthcare Partners sold out of Establishment Labs (ESTA) in Q4 2023, closing a stake of 60,530 shares — an estimated $2.97M sold.

Parkman Healthcare Partners first reported a position in ESTA in Q3 2022 and held it in 4 quarters. The position peaked at $3.99M in Q2 2023. 99 funds tracked by Wall St. Rank hold ESTA as of Q4 2023.

Parkman Healthcare Partners reported no remaining Establishment Labs position as of Q4 2023 after selling out during the quarter.
Parkman Healthcare Partners sold 60,530 Establishment Labs shares in Q4 2023, an estimated $2.97M.
Parkman Healthcare Partners first reported a position in Establishment Labs in Q3 2022 and held it in 4 quarters.
Parkman Healthcare Partners's Establishment Labs position peaked at $3.99M in Q2 2023.
99 funds tracked by Wall St. Rank held Establishment Labs as of Q4 2023.

Based on Parkman Healthcare Partners's 13F filing for Q4 2023, filed 14 Feb 2024.